Cargando…

Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction

Previous studies suggested an association between heart failure (HF) and hepatic disorders. Liver function parameters have been shown to predict outcome in HF with reduced ejection fraction, but their impact in HF with preserved ejection fraction (HFpEF) has not yet been investigated. Between Januar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalos, Daniel, Binder, Christina, Duca, Franz, Aschauer, Stefan, Kammerlander, Andreas, Hengstenberg, Christian, Mascherbauer, Julia, Reiberger, Thomas, Bonderman, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898583/ https://www.ncbi.nlm.nih.gov/pubmed/31811258 http://dx.doi.org/10.1038/s41598-019-55116-8

Ejemplares similares

Patients with Heart Failure and Preserved Ejection Fraction Are at Risk of Gastrointestinal Bleeding
por: Schrutka, Lore, et al.
Publicado: (2019)

Gender-related differences in heart failure with preserved ejection fraction
por: Duca, Franz, et al.
Publicado: (2018)

Presence of ´isolated´ tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction
por: Mascherbauer, Julia, et al.
Publicado: (2017)

Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters
por: Schönbauer, Robert, et al.
Publicado: (2019)

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial( )
por: Dachs, Theresa Marie, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death
por: Schrutka, Lore, et al.
Publicado: (2022)

Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance
por: Goliasch, Georg, et al.
Publicado: (2015)

Prognostic impact of left atrial function in heart failure with preserved ejection fraction in sinus rhythm vs. persistent atrial fibrillation
por: Schönbauer, Robert, et al.
Publicado: (2021)

Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction
por: Karakus, Gültekin, et al.
Publicado: (2015)

Right Atrial Phasic Function in Heart Failure with Preserved Ejection Fraction: Cardiac Magnetic Resonance Feature Tracking and Outcomes
por: Schönbauer, Robert, et al.
Publicado: (2023)

Prevalence and prognostic significance of right ventricular systolic dysfunction in heart failure with preserved ejection fraction. Insights from a cardiac magnetic resonance imaging study
por: Aschauer, Stefan, et al.
Publicado: (2015)

Heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevant
por: Kammerlander, Andreas A., et al.
Publicado: (2021)

Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling: Ready for prime time?
por: Kammerlander, Andreas A., et al.
Publicado: (2017)

What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection Fraction
por: Rettl, René, et al.
Publicado: (2020)

Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction: Study protocol for a randomized controlled trial
por: Mascherbauer, Julia, et al.
Publicado: (2016)

Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping
por: Antlanger, Marlies, et al.
Publicado: (2018)

Epicardial fat volume is inversely correlated with the degree of diastolic dysfunction and outcome in patients with heart failure with preserved ejection fraction
por: Karakus, Gültekin, et al.
Publicado: (2013)

Diffuse myocardial fibrosis by post-contrast T1-time predicts outcome in heart failure with preserved ejection fraction
por: Marzluf, Beatrice A, et al.
Publicado: (2013)

Cardiac remodeling in ambitious endurance-trained amateur athletes older than 50 years–an observational study
por: Dalos, Daniel, et al.
Publicado: (2022)

Machine Learning Enables Prediction of Cardiac Amyloidosis by Routine Laboratory Parameters: A Proof-of-Concept Study
por: Agibetov, Asan, et al.
Publicado: (2020)

Extracellular matrix expansion by cardiac magnetic resonance T1 mapping- validation with myocardial biopsy
por: Kammerlander, Andreas, et al.
Publicado: (2015)

Gamma-Glutamyltransferase Fractions in Human Plasma and Bile: Characteristic and Biogenesis
por: Fornaciari, Irene, et al.
Publicado: (2014)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Renin Feedback Is an Independent Predictor of Outcome in HFpEF
por: Binder, Christina, et al.
Publicado: (2021)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Serum Gamma-glutamyltransferase and Obesity: is there a Link?
por: Coku, Viko, et al.
Publicado: (2018)

Light‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome
por: Nitsche, Christian, et al.
Publicado: (2020)

Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma?
por: Foddis, Rudy, et al.
Publicado: (2022)

Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging
por: Agibetov, Asan, et al.
Publicado: (2021)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
por: Zordoky, Beshay N., et al.
Publicado: (2015)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2016)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h8g0vv1qgeji244ichjstq3ogn